TRIALHEALTH
Live / Applied — Ex parte appeal pending (as of 17 Sept 2026)
What this means for you
Not registered yet, but its 15 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98802414
- Mark type
- Word mark
- Filed
- 15 Oct 2024
- Attorney of record
- KENYA WILLIAMS
Goods and services
- Class 035 — Advertising and business services: Business management of clinical trials for others; recruitment of clinical drug trial participants, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; marketing of healthcare and pharmaceutical products of others; compiling information into computer databases, namely, collecting and compiling consumer preference information regarding health conditions, clinical trial participation interest, and clinical trial candidacy for business purposes; collection of market research information, namely, collecting and compiling clinical trial statistics and information for business purposes
Owner
- Synexus Clinical Research US, Inc., Wilmington, NC, US
Board proceedings on this mark
- Ex Parte Appeal No. 98802414 — Synexus Clinical Research US, Inc., filed 27 Jul 2026 (Pending)
Prosecution history
- 16 Sept 2026 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 16 Sept 2026 — ACTION DENYING REQ FOR RECON E-MAILED
- 16 Sept 2026 — ACTION CONTINUING FINAL - COMPLETED
- 27 Aug 2026 — EX PARTE APPEAL-INSTITUTED
- 27 Aug 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 27 Aug 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 26 Aug 2026 — NOTICE OF REVIVAL - E-MAILED
- 26 Aug 2026 — PETITION GRANTED - TTAB APPEAL FILED
- 25 Aug 2026 — ASSIGNED TO PETITION STAFF
- 28 Jul 2026 — EXPARTE APPEAL RECEIVED AT TTAB
- 27 Jul 2026 — TEAS PETITION TO REVIVE RECEIVED
- 26 May 2026 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 26 May 2026 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 09 Feb 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 09 Feb 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED